• LAST PRICE
    0.0198
  • TODAY'S CHANGE (%)
    Trending Down-0.0002 (-1.0000%)
  • Bid / Lots
    0.0130/ 260
  • Ask / Lots
    0.0199/ 100
  • Open / Previous Close
    0.0198 / 0.0200
  • Day Range
    Low 0.0198
    High 0.0198
  • 52 Week Range
    Low 0.0110
    High 0.0495
  • Volume
    2,116
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.0198
TimeVolumeNXEN
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNXEN
Nexien Biopharma Inc
1.4M
-5.5x
---
United StatesPRFX
PainReform Ltd
1.3M
0.0x
---
United StatesCNNA
Cann American Corp
1.2M
0.0x
---
United StatesCYTO
Altamira Therapeutics Ltd
1.7M
0.6x
---
United StatesITNS
ITonis Inc
609.4K
-0.4x
---
United StatesLRSV
Link Reservations Inc
951.4K
0.0x
---
As of 2024-11-14

Company Information

Nexien BioPharma, Inc. is engaged in pre-clinical and drug development activities for certain pharmaceutical formulations that include cannabinoids. The Company is focused on developing and commercializing United States Food and Drug Administration (FDA)-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders and medical conditions. The Company is utilizing cannabinoids as the active pharmaceutical ingredients to develop synthetic pharmaceuticals in strict accordance with the U.S. FDA pre-clinical and clinical pathways. Its flagship research and development programs are focused on advancing formulations that have the potential to improve the treatment outcomes of certain convulsive disorders and neuromuscular disorders, which includes the treatment of myotonic dystrophy. The Company's wholly owned subsidiaries include Intiva BioPharma Inc., NexN Inc. (NexN) and NexDM Inc.

Contact Information

Headquarters
4340 E Kentucky Ave Ste 206GLENDALE, CO, United States 80246-2067
Phone
303-495-7583
Fax
302-645-1280

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.4M
Revenue (TTM)
$0.00
Shares Outstanding
70.8M
Nexien Biopharma Inc does not pay a dividend.
Beta
0.64
EPS
$0.00
Book Value
$-0.01
P/E Ratio
-5.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.